The international segment reported revenue of A$421.4 million, up 33% year-on-year, contributing A$55.8m to normalised earnings before interest and tax, up 91.3%.
Gross profit for the international segment lifted 47.6% from A$87.4m to A$128.9m, with gross margin lifting 303 basis points from 27.57% to 30.6%.
The company said New Zealand “led the way”, with sales growth of 20.3% year-on-year and network store sales exceeding $1b.
Chemist Warehouse has more than 3000 employees in New Zealand.
“New Zealand continued to deliver compelling momentum in FY26, reinforcing its position as a significant and scalable growth market for the group,” the company said.
“The business opened 14 new stores during the year, including Palmerston North, which delivered the strongest opening sales week ever recorded across the Chemist Warehouse Group globally.”
Within Sigma Healthcare’s annual report was detail on how it plans to reinforce its growth and momentum in the New Zealand market.
As of June 30, 2026, six new Chemist Warehouse locations are under construction, bringing the New Zealand network to 81 stores.
However, the company also noted an additional 20 leases have been signed, providing a pathway to more than 100 stores. No locations were disclosed at this stage.
To support the planned increase in New Zealand stores, Sigma Healthcare invested about A$40m in May in a new 23,000sq m distribution centre in Auckland.
The centre is nearly online and expected to start operations next month.
Sigma Healthcare’s wider group reported total revenue of A$10.8b, up 15.5% year-on-year, with a normalised net profit of A$732.2m, up 22.3%.
Tom Raynel is a multimedia business journalist for the Herald, covering small business, retail and tourism.
Stay ahead with the latest market moves, corporate updates, and economic insights by subscribing to our Business newsletter – your essential weekly round-up of all the business news you need.